Case of Aortic Stenosis

97 views
Skip to first unread message

DR VIDHI GHAG (KADAM)

unread,
Aug 9, 2010, 7:39:48 AM8/9/10
to Madhavbaug
35 yr male patient having C/O Chest pain,Acidity with burping
(Amlodgaar)
O/E BP = 110/70 mm of Hg,
Murmurs heard.
2D echo reports -
Moderate Aortic Stenosis
Trival Aortic Regurgitation
Concentric LVH
Trival tricuspid Regurgitation
LVEF = 70%


What can be done for this patient?How SHS will help in this case?What
oral medicines can be given and how will it act?

Suhas Dawkhar

unread,
Aug 10, 2010, 9:24:56 AM8/10/10
to madha...@googlegroups.com
Along with ARJ, AVPC will be a good option as it will improve digestion hence regulate pitta flow.. and to be given in pitta kaal
You may also combine it with Symune Syrup.. in the same kaal.
 
SHS will surely help in this case ..i have already treated similar cases.
It is a bit difficult to exactly comment on the origin of the chest pain without seeing ECG but there should be a significant role of indigestion and Acidity because LVEF is 70% and if at all it is of exclusively cardiac origin ...SHS should be mostly focussed on hrud dhara and snehan....
Constipation should also be avoided..
 
This Rx will surely give a satisfactory result.. further more keep in tuch!!

Rohitmsane

unread,
Aug 17, 2010, 5:50:12 AM8/17/10
to Madhavbaug
SHS will surely act on this disorder.
Ejection fraction of 70% denotes that the cardiac muscles are under a
constant strain which is seen as LVH. This strain is due to Aortic
stenosis. So one has to treat Aortic stenosis.
Now the patient is seen to complain of Amlodgar. This means that the
Vat in the HRUD pradesh is travelling in upward direction with heavy
pressure.
This upward direction to the Vat is given by the aortic stenosis. I ll
explain:
In aortic stenosis, the blood is not able to come out of the heart
hence more pressure is exerted by the vat on the valve to get the
blood out.
Same vat handles the pitta in the stomach too. When this vat gets in a
problem in heart, it shows the same problem in stomach, hence
amlodgar.
One needs to go ahead for VIRECHAN to get rid of Aortic stenosis,
acidity, burping and amlodgar.
Nishottar will be the best active principle present in AVPC.
Vekhand is called as a Hurday shodhak, hence it can be used in this
disorder too.
SHS will obviously help in this patient as the after effects of Aortic
stenosis which lead to Heart failure need to be tackled along with the
above things.
I hope I have made amny things clear.
Let me know if anything more is to be explained.

On Aug 9, 4:39 pm, "DR VIDHI GHAG (KADAM)" <drvidhi2...@gmail.com>
wrote:

Suhas Dawkhar

unread,
Aug 25, 2010, 6:47:44 AM8/25/10
to madha...@googlegroups.com
Excruciating and radiating jaw pain is a common feature in post MI patients.. which the patient wants to get rid off first of all...once that subsides the patient is comfortable for the rest of the treatmentso..
So what can be the medicinal and therapeutic treatment for the same.. other than C-lep !!?
 

Dr Rohit Sane

unread,
Aug 26, 2010, 1:31:45 PM8/26/10
to madha...@googlegroups.com

Document title

Efficacy of Terminalia arjuna in chronic stable angina: A double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate

Auteur(s) / Author(s)

BHARANI Anil ; GANGULI Arunangshu ; MATHUR L. K. ; JAMRA Yogendra ; RAMAN P. G. ;

Résumé / Abstract

Background: Terminalia arjuna, an Indian medicinal plant, has been reported to have beneficial effects in patients with ischemic heart disease in a number of small, open studies. The need for a double-blind, randomized, placebo-controlled study with adequate sample size has long been felt. The bark extract (IPC-53) contains acids (arjunic acid, terminic acid), glycosides (arjunetin arjunosides I-IV), strong antioxidants (flavones, tannins, oligomeric proanthocyanidins), minerals, etc. and exhibits antifailure and anti-ischemic properties. Methods and Results: Fifty-eight males with chronic stable angina (NYHA class II-III) with evidence of provocable ischemia on treadmill exercise test received Terminalia arjuna (500 mg 8 hourly), isosorbide mononitrate (40 mg/daily) or a matching placebo for one week each, separated by a wash-out period of at least three days in a randomized, double-blind, crossover design. They underwent clinical, biochemical and treadmill exercise evaluation at the end of each therapy which were compared during the three therapy periods. Terminalia arjuna therapy was associated with significant decrease in the frequency of angina and need for isosorbide dinitrate (5.69′6.91 mg/week v. 18.22′9.29 mg/week during placebo therapy, p<0.005). The treadmill exercise test parameters improved significantly during therapy with Terminalia arjuna compared to those with placebo. The total duration of exercise increased (6.14′2.51 min v. 4.76′2.38 min, p<0.005), maximal ST depression during the longest equivalent stages of submaximal exercise decreased (1.41′0.55 mm v. 2.21′0.56 mm, p<0.005), time to recovery decreased (6.49′2.37 min v. 9.27′3.39 min, p<0.005) and higher double products were achieved (25.75′4.81×103v. 23.11′4.83×103, p<0.005) during Terminalia arjuna therapy. Similar improvements in clinical and treadmill exercise test parameters were observed with isosorbide mononitrate compared to placebo therapy. No significant differences were observed in clinical or treadmill exercise test parameters when Terminalia arjuna and isosorbide mononitrate therapies were compared. No significant untoward effects were reported during Terminalia arjuna therapy. Conclusions: Terminalia arjuna bark extract, 500 mg 8 hourly, given to patients with stable angina with provocable ischemia on treadmill exercise, led to improvement in clinical and treadmill exercise parameters as compared to placebo therapy. These benefits were similar to those observed with isosorbide mononitrate (40 mg/day) therapy and the extract was well tolerated. Limitations of this study include applicability of the results to only men with chronic stable angina but not necessarily to women, as they were not studied.

Revue / Journal Title

Indian Heart Journal    ISSN  0019-4832 

Source / Source

2002, vol. 54, no2, pp. 170-175 [6 page(s) (article)]
--
Dr Rohit Sane
Madhavbaug
"Madhavbaug" is the world's first ISO certified Ayurvedic Cardiac Rehabilitation Centre. To have a look at Madhavbaug, kindly click on the following video link.

http://www.youtube.com/watch?v=YVXdWQ_LClc

Heart patients with various amount of blockages who refuse bypass surgery and angioplasty, get admitted in Madhavbaug for their treatment.
"Sampurna Hridaya Shuddhikaran" a copyrited Ayurvedic Panchakarma treatment procedure is the main pillar of Madhavbaug treatment.
Various TV channels like CNBC and Zee TV have helped many patients by putting forth this non invasive, safe procedure in front of their viewers.
To have a look, kindly follow the following video link.

CNBC coverage
http://www.youtube.com/watch?v=9XdADyBWvpA

Zee Tv coverage
http://www.youtube.com/watch?v=UGhxRtZ1jfU

Patients who could not even walk for 100 meters due to heart disease have participated in a Sports day and completed it successfully after their treatment at Madhavbaug. To have a look at the Sports day, kindly follow this video link.

http://www.youtube.com/watch?v=_JgfXvbJn_o


For more details about Madhavbaug, visit www.madhavbaug.org

Dr. Rohit M. Sane
Sanegroup
www.madhavbaug.org

Reply all
Reply to author
Forward
0 new messages